A drug that would have been a combination treatment for diabetes and high cholesterol will no longer be developed, according to an article in the Wall Street Journal.

The FDA has approved Juvisync, a prescription medication that contains two previously approved medicines in one tablet: Januvia (sitagliptin) for diabetes and Zocor (simvastatin) for high cholesterol.